Melanoma overdiagnosis: why it matters and what can be done about it – Katy Bell & Tamar Nijsten
Cancer screening aims to reduce morbidity and mortality through early detection of preclinical disease. These potential benefits must be weighed against potential harms from diagnostic procedures, induced anxiety, false-positive or false-negative results and the detection of ‘indolent’ cancers, otherwise known as overdiagnosis.